Influence of Ribosomal Protein L39-L in the Drug Resistance Mechanisms of Lacrimal Gland Adenoid Cystic Carcinoma Cells |
Ye, Qing
(Department of Ophthalmology, Jining First People's Hospital)
Ding, Shao-Feng (Department of Endocrinology, Jining First People's Hospital) Wang, Zhi-An (Department of Ophthalmology, Jining First People's Hospital) Feng, Jie (Department of Endocrinology, Jining First People's Hospital) Tan, Wen-Bin (Department of Basical Medicine, Jining Medical University) |
1 | Rocas D, Asvesti C, Tsega A, et al (2013). Primary adenoid cystic carcinoma of the skin metastatic to the lymph nodes: immunohistochemical study of a new case and literature review. Am J Dermatopath, 36, 223-8. |
2 | Hong L, Han Y, Zhang H, et al (2014). Drug resistance-related mirnas in hepatocellular cancer. Expert Rev Gastroent, 8, 283-8. DOI ScienceOn |
3 | Chang Cy, Cheng Sl, Chang Sc (2011). Adenoid cystic carcinoma of trachea treated with tumor curettage and adjuvant intensity modulated radiation therapy. Southern Med J, 104, 68-70. DOI ScienceOn |
4 | Fishman MN (2013). Targeted therapy of kidney cancer: keeping the art around the algorithms. Cancer Control, 20, 222-32. DOI |
5 | Iqbal H, Bhatti Ab, Hussain R, Jamshed A (2014). Ten year experience with surgery and radiation in the management of malignant major salivary gland tumors. Asian Pac J Cancer Prev, 15, 195-9. 과학기술학회마을 DOI ScienceOn |
6 | Jaafari Z, Ashraf Mj, Moshaverinia M (2013). Salivary gland tumors: a clinicopathologic study of 366 cases in southern Iran. Asian Pac J Cancer Prev, 14, 27-30. 과학기술학회마을 DOI ScienceOn |
7 | Jensen Ad, Nikoghosyan A, Hinke A, et al (2011). Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(R) and particle therapy]. BMC Cancer, 11, 70. DOI |
8 | Kaur P, Khurana A, Chauhan Ak, et al (2013). Adenoid cystic carcinoma of cervix: treatment strategy. J Clin Diag Res, 7, 2596-7. |
9 | Kim M, Lee Dw, Im J, et al (2014). Adenoid cystic carcinoma of the breast: a case series of six patients and literature review. Cancer Res Treat, 46, 93-7. DOI ScienceOn |
10 | Kondo S, Mukudai Y, Soga D, et al (2014). Differential expression of vascular endothelial growth factor in high- and low-metastasis cell lines of salivary gland adenoid cystic carcinoma. Anticancer Res, 34, 671-7. |
11 | Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801. DOI ScienceOn |
12 | Canadas I, Rojo F, Taus A, et al (2014). Targeting epithelialto-mesenchymal transition with met inhibitors reverts chemoresistance in small cell lung cancer. Clin Cancer Res, 20, 938-50. DOI ScienceOn |
13 | Sugihara Y, Honda H, Iida T, et al (2010). Proteomic analysis of rodent ribosomes revealed heterogeneity including ribosomal proteins L10-like, L22-like 1, and L39-like. J Proteome Res, 9, 1351-66. DOI ScienceOn |
14 | Tadbir AA, Pardis S, Ashkavandi ZJ, et al (2012). Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pac J Cancer Prev, 13, 5155-9. 과학기술학회마을 DOI ScienceOn |
15 | Saijo N (2012). Present status and problems on molecular targeted therapy of cancer. Cancer Res Treat, 44, 1-10. DOI ScienceOn |
16 | Shen C, Xu T, Huang C, et al (2012). Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck. Oral Oncol, 48, 445-9. DOI ScienceOn |
17 | Tan W, Sun L, Zhang D, et al (2007). Cloning and overexpression of ribosomal protein L39 gene from deltamethrin-resistant Culex pipiens pallens. Exp Parasitology, 115, 369-78. DOI ScienceOn |
18 | Tay Z, Koo SH, Nguyen TT, et al (2014). P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells. Curr Med Chem, 21, 251-60. |
19 | Wang L, Wang Y, Bian H, et al (2013). Molecular characteristics of homologous salivary adenoid cystic carcinoma cell lines with different lung metastasis ability. Oncol Rep, 30, 207-12. DOI |
20 | Zhao X, Li H, Bao T (2013). Analysis on the interaction between post-spliced introns and corresponding protein coding sequences in ribosomal protein genes. J Theor Biol, 328, 33-42. DOI ScienceOn |
21 | Bradley EA, Bradley DJ (2013). Adenoid cystic carcinoma of the lacrimal gland: rare ... lethal ... cured? Ophthalmology, 120, 1311-2. DOI ScienceOn |
22 | Lippert Th, Ruoff Hj, Volm M (2014). Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment? Ther Clin Risk Manag, 10, 69-72. |
23 | Koshkin V, Krylov Sn (2012). Correlation between multi-drug resistance-associated membrane transport in clonal cancer cells and the cell cycle phase. PloS One, 7, 41368. DOI |
24 | Ashkavandi ZJ, Najvani AD, Tadbir AA (2013). MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors. Asian Pac J Cancer Prev, 14, 3479-82. 과학기술학회마을 DOI ScienceOn |
25 | Maeda O, Ando T, Ohmiya N, et al (2014). Alteration of gene expression and DNA methylation in drug-resistant gastric cancer. Oncol Rep, 10, 3014. |
26 | Martinez-Rodriguez N, Leco-Berrocal I, Rubio-Alonso L, et al (2011). Epidemiology and treatment of adenoid cystic carcinoma of the minor salivary glands: a meta-analytic study. Med Oral Patol Oral Cir Bucal, 16, 884-9. |
27 | Mccormack Va, Schuz J (2012). Africa's growing cancer burden: environmental and occupational contributions. Cancer Epidemiol, 36, 1-7. DOI ScienceOn |
28 | Nadano D, Notsu T, Matsuda T, et al (2002). A human gene encoding a protein homologous to ribosomal protein L39 is normally expressed in the testis and derepressed in multiple cancer cells. Biochim Biophys Acta, 1577, 430-6. DOI ScienceOn |
29 | Petrov A, Meskauskas A, Dinman Jd (2004). Ribosomal protein L3: influence on ribosome structure and function. RNA Biol, 1, 59-65. |
30 | Takebayashi K, Mekata E, Sonoda H, et al (2013). Differences in chemosensitivity between primary and metastatic tumors in colorectal cancer. PloS One, 8, 73215. DOI |
31 | Cree IA (2013). Designing personalised cancer treatments. J Control Release, 172, 405-9. DOI ScienceOn |
![]() |